Hepatitis C, Acute Completed Phase 4 Trials for Peginterferon alfa-2a (DB00008)

Also known as: Acute Hepatitis C / Acute hepatitis C NOS

IndicationStatusPhase
DBCOND0076207 (Hepatitis C, Acute)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01336010Treatment of Recently Acquired Hepatitis C Virus InfectionTreatment
NCT02377856Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute InfectionTreatment